BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17593344)

  • 21. Docking and fusion of insulin secretory granules in SUR1 knock out mouse beta-cells observed by total internal reflection fluorescence microscopy.
    Kikuta T; Ohara-Imaizumi M; Nakazaki M; Nishiwaki C; Nakamichi Y; Tei C; Aguilar-Bryan L; Bryan J; Nagamatsu S
    FEBS Lett; 2005 Mar; 579(7):1602-6. PubMed ID: 15757648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Pflugers Arch; 1999 Feb; 437(3):400-8. PubMed ID: 9914396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
    Moritz W; Leech CA; Ferrer J; Habener JF
    Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
    Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
    Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.
    Muñoz A; Hu M; Hussain K; Bryan J; Aguilar-Bryan L; Rajan AS
    Endocrinology; 2005 Dec; 146(12):5514-21. PubMed ID: 16123162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.
    Meyer M; Chudziak F; Schwanstecher C; Schwanstecher M; Panten U
    Br J Pharmacol; 1999 Sep; 128(1):27-34. PubMed ID: 10498831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of two amino acids in TM17 of Sulfonylurea receptor SUR1 on the binding of ATP-sensitive K+ channel modulators.
    Hambrock A; Kayar T; Stumpp D; Osswald H
    Diabetes; 2004 Dec; 53 Suppl 3():S128-34. PubMed ID: 15561900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfonylurea receptor knockout causes glucose intolerance in mice that is not alleviated by concomitant somatostatin subtype receptor 5 knockout.
    Norman M; Moldovan S; Seghers V; Wang XP; DeMayo FJ; Brunicardi FC
    Ann Surg; 2002 Jun; 235(6):767-74. PubMed ID: 12035032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
    Hansen AM; Hansen JB; Carr RD; Ashcroft FM; Wahl P
    Br J Pharmacol; 2005 Feb; 144(4):551-7. PubMed ID: 15678092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1.
    Flagg TP; Kurata HT; Masia R; Caputa G; Magnuson MA; Lefer DJ; Coetzee WA; Nichols CG
    Circ Res; 2008 Dec; 103(12):1458-65. PubMed ID: 18974387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.
    Tanemoto M; Vanoye CG; Dong K; Welch R; Abe T; Hebert SC; Xu JZ
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F659-66. PubMed ID: 10751228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epinephrine-induced hyperpolarization of islet cells without KATP channels.
    Sieg A; Su J; Muñoz A; Buchenau M; Nakazaki M; Aguilar-Bryan L; Bryan J; Ullrich S
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E463-71. PubMed ID: 14613926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
    Lim JG; Lee HY; Yun JE; Kim SP; Park JW; Suh SI; Jang BC; Cho CH; Bae JH; Kim SS; Han J; Park MJ; Song DK
    Biochem Pharmacol; 2004 Sep; 68(5):901-10. PubMed ID: 15294453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose.
    Shiota C; Larsson O; Shelton KD; Shiota M; Efanov AM; Hoy M; Lindner J; Kooptiwut S; Juntti-Berggren L; Gromada J; Berggren PO; Magnuson MA
    J Biol Chem; 2002 Oct; 277(40):37176-83. PubMed ID: 12149271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A signaling role of glutamine in insulin secretion.
    Li C; Buettger C; Kwagh J; Matter A; Daikhin Y; Nissim IB; Collins HW; Yudkoff M; Stanley CA; Matschinsky FM
    J Biol Chem; 2004 Apr; 279(14):13393-401. PubMed ID: 14736887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
    Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
    Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
    Stephan D; Winkler M; Kühner P; Russ U; Quast U
    Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
    Gros L; Virsolvy A; Salazar G; Bataille D; Blache P
    Biochem Biophys Res Commun; 1999 Apr; 257(3):766-70. PubMed ID: 10208857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs acting on SUR1 to treat CNS ischemia and trauma.
    Simard JM; Woo SK; Bhatta S; Gerzanich V
    Curr Opin Pharmacol; 2008 Feb; 8(1):42-9. PubMed ID: 18032110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.